Impact BioMedical Demonstrates 10-Fold Reduction in Viral Population of COVID-19 in Surface Disinfectant Efficacy Testing of its 3F Antiviral Biofragrance

ROCHESTER\, N.Y.\, Sept. 17\, 2020 (GLOBE NEWSWIRE) -- Document Security Systems\, Inc. (“DSS” or the “Company”) (NYSE American: DSS)\, a multinational company operating businesses focusing on brand protection technology\, blockchain security\, direct marketing\, healthcare\, real estate\, and securitized digital assets\, today announced its wholly owned subsidiary Impact BioMedical\, In